These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26626120)

  • 1. Novel insights into immunotherapy for hepatitis B patients.
    Akbar SM; Al-Mahtab M; Jahan M; Yoshida O; Hiasa Y
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):267-76. PubMed ID: 26626120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus.
    Gill US; Bertoletti A
    Semin Liver Dis; 2017 May; 37(2):85-94. PubMed ID: 28564718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
    Akbar SM; Al-Mahtab M; Khan MS
    Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.
    Zhang E; Kosinska A; Lu M; Yan H; Roggendorf M
    Antiviral Res; 2015 Nov; 123():193-203. PubMed ID: 26476376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic targets and drugs for the treatment of chronic hepatitis B.
    Fletcher SP; Delaney WE
    Semin Liver Dis; 2013 May; 33(2):130-7. PubMed ID: 23749669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics.
    Chang KM; Liu M
    Curr Opin Pharmacol; 2016 Oct; 30():93-105. PubMed ID: 27570126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies.
    Isorce N; Lucifora J; Zoulim F; Durantel D
    Antiviral Res; 2015 Oct; 122():69-81. PubMed ID: 26275801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune therapeutic strategies in chronic hepatitis B virus infection: virus or inflammation control?
    Bertoletti A; Gehring AJ
    PLoS Pathog; 2013; 9(12):e1003784. PubMed ID: 24367255
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel approaches towards conquering hepatitis B virus infection.
    Wu GY; Chen HS
    World J Gastroenterol; 2007 Feb; 13(6):830-6. PubMed ID: 17352010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs in Development for Hepatitis B.
    Dawood A; Abdul Basit S; Jayaraj M; Gish RG
    Drugs; 2017 Aug; 77(12):1263-1280. PubMed ID: 28660478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
    Wang FS; Zhang JY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon therapy of chronic hepatitis B.
    Brunetto MR; Bonino F
    Intervirology; 2014; 57(3-4):163-70. PubMed ID: 25034484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies.
    Chen J; Yuan Z
    Virol Sin; 2014 Feb; 29(1):17-24. PubMed ID: 24452540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Up-to-date algorithms for diagnosis and treatment of chronic hepatitis B].
    Maev IV; Polunina TE; Polunina EV
    Klin Med (Mosk); 2009; 87(8):7-12. PubMed ID: 19827522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host factor-targeted hepatitis B virus therapies.
    Gehring A; Bertoletti A; Tavis JE
    Intervirology; 2014; 57(3-4):158-62. PubMed ID: 25034483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to new therapies for hepatitis B virus infection.
    Loomba R; Liang TJ
    Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.